With the aim of fostering a healthier society through accurate diagnostics, which facilitate further patient management, Agiomix offers routine diagnostics including basic and comprehensive laboratory tests.
We provide patients, doctors, clinics, polyclinics, and hospitals with relevant lab tests and routine medical tests that meet predefined quality standards. The laboratory is equipped with highly standardized and state-of-the-art analyzers and equipment. Our technicians and board members are highly qualified and experienced professionals.
Our categories include:
1. Hematology & Coagulation
2. Clinical Chemistry
3. Clinical Microscopy
4. Immunology/Serology
5. Profiles
CAP Proficiency Testing Statistics
Product Status | estimated availability | Application | Sub Group | Category | Sub Category | New Test Code | Test Name | Prefered sample type | Alternative sample type | Sample Vol/Min. Vol (ml) | Container | Turn Around Time | Sample Transport | Speciment Stability | Test Description | Technology/ Device | Pre Analytical Requisites/Test Limitation | Rejection Criteria | Output Report |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Live | 2021-04-17 00:00:00 | Routine Diagnostics | HEMATOLOGY & COAGULATION | 50000 | 51000 | 51101 | Complete Blood Count (CBC), Whole Blood | Whole Blood | 1/0.5 | EDTA | 1 Day | R.T/ 2-8 C | R.T.: 8 hr 2-8C: 24 hr Frozen: NA | Complete Blood Count,Whole Blood | See individual tests | NA | G1 | Clinical report | |
Live | 2021-04-17 00:00:00 | Routine Diagnostics | HEMATOLOGY & COAGULATION | 50000 | 51000 | 51102 | Haemoglobin,Whole Blood | Whole Blood | 1/0.5 | EDTA | 1 Day | R.T/ 2-8 C | R.T.: 8 hr 2-8C: 24 hr Frozen: NA | Haemoglobin,Whole Blood | Sodium lauryl sulphate | NA | G1 | Clinical report | |
Live | 2021-04-17 00:00:00 | Routine Diagnostics | HEMATOLOGY & COAGULATION | 50000 | 51000 | 51103 | Hematocrit (Packed Cell Volume), Whole Blood | Whole Blood | 2/0.5 | EDTA | 1 Day | R.T/ 2-8 C | R.T.: 8 hr 2-8C: 24 hr Frozen: NA | Hematocrit (Packed Cell Volume), Blood | autocalculation by analyzer | NA | G1 | Clinical report | |
Live | 2021-04-17 00:00:00 | Routine Diagnostics | HEMATOLOGY & COAGULATION | 50000 | 51000 | 51104 | Platelet Count, Automated, Blood | Whole Blood | 1/0.5 | EDTA | 1 Day | R.T/ 2-8 C | R.T.: 8 hr 2-8C: 24 hr Frozen: NA | Platelet Count, Automated, Blood | Electrical impedance | NA | G1 | Clinical report | |
Phase II | 2021-04-17 00:00:00 | Routine Diagnostics | HEMATOLOGY & COAGULATION | 50000 | 51000 | 51105 | Erythrocyte Sedimentation Rate; ESR | Whole Blood | 2/0.5 | Black | 1 Day | 2-8 C | R.T.: 8 hr 2-8C: 24 hr Frozen: NA | Erythrocyte Sedimentation Rate; ESR | Modified Westergren method | NA | G3 | Clinical report | |
Phase II | 2021-04-17 00:00:00 | Routine Diagnostics | HEMATOLOGY & COAGULATION | 50000 | 51000 | 51106 | Prothrombin Time,Plasma | Citrated Plasma | 1/0.5 | Blue | 1 Day | Plasma, Frozen | R.T( plasma): 4 hr . 2-8C Temperature: N/A Frozen ( plasma): 24 hr | Prothrombin Time,Plasma (PT) | Mechanical Clot Detection | NA | G1 | Clinical report | |
Phase II | 2021-04-17 00:00:00 | Routine Diagnostics | HEMATOLOGY & COAGULATION | 50000 | 51000 | 51107 | Partial Thromboplastin Time,Plasma | Citrated Plasma | 1/0.5 | Blue | 1 Day | Plasma, Frozen | R.T( plasma): 4 hr . 2-8C Temperature: N/A Frozen ( plasma): 24 hr | Partial Thromboplastin Time,Plasma (PTT) | Mechanical Clot Detection | NA | G1 | Clinical report | |
HEMATOLOGY & COAGULATION | 50000 | 51000 | 51109 | ADAMTS-13 Activity ELISA Testing | Citrated human plasma | 2 ml | Blue | 2 days | frozen | R.T.: 2hr Frozen: Once≤ -20°C | Determination of ADAMTS-13 enzymatic activity using CE-IVD reagents and protocol | G1 | Clinical report | ||||||
Under Validation | N/A | Routine Diagnostics | Clinical Chemistry | 50000 | 52000 | 52101 | Glucose Fasting, Serum | Serum | Plasma | 1/0.5 | G/GR (Plasma) or R/Y (Serum) | 1 Day | Fluoride tube only. (2-8 C) | RT(15-25°C) 2 d 2-8C(2-8°C) 7 d | Glucose, Fasting Blood | Hexokinase | 8-12hr fasting | G1. Non-fasting sample | Clinical report |
Under Validation | N/A | Routine Diagnostics | Clinical Chemistry | 50000 | 52000 | 52102 | Glucose, Random, Serum | Serum | Plasma | 1/0.5 | G/GR (Plasma) or R/Y (Serum) | 1 Day | Fluoride tube only. (2-8 C) | R.T.: 8 hr 2-8C: 3 d Frozen: 7 d | Glucose, Random | Hexokinase | NA | G1 | Clinical report |
Under Validation | N/A | Routine Diagnostics | Clinical Chemistry | 50000 | 52000 | 52103 | Glucose Tolerance Test (75gms), Plasma | Serum | Plasma | 1/0.5 | G/GR (Plasma) or R/Y (Serum) | 1 Day | Fluoride tube only. (2-8 C) | RT(15-25°C) 2 d 2-8C(2-8°C) 7 d | Glucose Tolerance Test (75gms), Plasma | Hexokinase | 8-12hr fasting | G1 | Clinical report |
Under Validation | N/A | Routine Diagnostics | Clinical Chemistry | 50000 | 52000 | 52104 | Glucose Postprandial, Blood | Serum | Plasma | 1/0.5 | G/GR (Plasma) or R/Y (Serum) | 1 Day | Fluoride tube only. (2-8 C) | RT(15-25°C) 2 d 2-8C(2-8°C) 7 d | Glucose, Postprandial, Blood | Hexokinase | 2 hr after food | G1 | Clinical report |
Under Validation | N/A | Routine Diagnostics | Clinical Chemistry | 50000 | 52000 | 52105 | Cholesterol Total, Serum | Serum | Plasma | 1/0.5 | G (Plasma) or R/Y (Serum) | 1 Day | 2-8 C | R.T.: 8 hr 2-8C: 7 d Frozen: 7 d | Cholesterol, Serum | Cholesterol Oxidase | NA | G1 | Clinical report |
Under Validation | N/A | Routine Diagnostics | Clinical Chemistry | 50000 | 52000 | 52106 | Triglycerides, Serum | Serum | Plasma | 1/0.5 | G (Plasma) or R/Y (Serum) | 1 Day | 2-8 C | RT(15-25°C) 2 d 2-8C(2-8°C) 7 d | Triglycerides,Serum | Enzymatic - GPO/PAP | NA | G1 | Clinical report |
Under Validation | N/A | Routine Diagnostics | Clinical Chemistry | 50000 | 52000 | 52107 | Cholesterol HDL, Serum | Serum | Plasma | 1/0.5 | G (Plasma) or R/Y (Serum) | 1 Day | 2-8 C | R.T.: 8 hr 2-8C: 7 d Frozen: 7 d | Cholesterol HDL, Serum | Immune-inhibition, CHO/PAP | Patients are required to fast for 12-hr prior to blood collection | G1 | Clinical report |
Under Validation | N/A | Routine Diagnostics | Clinical Chemistry | 50000 | 52000 | 52108 | LDL Cholesterol Direct, Serum | Serum | Plasma | 1/0.5 | G (Plasma) or R/Y (Serum) | 1 Day | 2-8 C | R.T.: 8 hr 2-8C: 3 d Frozen: 7 d | Cholesterol LDL, Serum | Protecting agent, CHO/PAP | Patient should be 12 hr fasting, preferred not mandatory | G1 | Clinical report |
Under Validation | N/A | Routine Diagnostics | Clinical Chemistry | 50000 | 52000 | 52109 | Lipid Profile,Serum (Available in Profile Section) | Serum | Plasma | 2/0.5 | G (Plasma) or R/Y (Serum) | 1 Day | 2-8 C | R.T.: 8 hr 2-8C: 7 d Frozen: 7 d | Lipid Profile,Serum | Direct | Patient should be 12 hr fasting | G1, Non-Fasting sample: Triglyceride cannot be performed. | Clinical report |
Under Validation | N/A | Routine Diagnostics | Clinical Chemistry | 50000 | 52000 | 52110 | Aspartate Aminotransferase (AST / SGOT), Serum | Serum | Plasma | 1/0.5 | G (Plasma) or R/Y (Serum) | 6 hours | 2-8 C | RT(15-25°C) 4 d 2-8C(2-8°C) 7 d | SGOT (AST), Serum | Kinetic UV (IFCC std) | NA | G1- (even slight hemolysis) | Clinical report |
Under Validation | N/A | Routine Diagnostics | Clinical Chemistry | 50000 | 52000 | 52111 | Alanine Aminotransferase (ALT / SGPT), Serum | Serum | Plasma | 1/0.5 | G (Plasma) or R/Y (Serum) | 6 hours | 2-8 C | RT(15-25°C) 3 d 2-8C(2-8°C) 7 d | SGPT (ALT), Serum | Kinetic UV (IFCC std) | NA | G1 | Clinical report |
Under Validation | N/A | Routine Diagnostics | Clinical Chemistry | 50000 | 52000 | 52112 | Alkaline phosphatase (ALP), Serum | Serum | Plasma | 1/0.5 | G (Plasma) or R/Y (Serum) | 6 hours | 2-8 C | R.T.: 8 hr 2-8C: 7 d Frozen: 7 day | Alkaline Phosphatase,Serum | PNPP | NA | G1 | Clinical report |
Under Validation | N/A | Routine Diagnostics | Clinical Chemistry | 50000 | 52000 | 52113 | Bilirubin Total, Serum | Serum | Plasma | 2/0.5 | G (Plasma) or R/Y (Serum) | 6 hours | 2-8 C | RT(15-25°C): 1 d 2-8C(2-8°C): 7 d Frozen: 7 d. (Protect from light by wrapping a spun SST® in foil or transferring serum or plasma to an amber transport vial. Avoid hemolysis.) | Bilirubin Total, Serum | DPD | NA | G1. Also See sample stability. | Clinical report |
Under Validation | N/A | Routine Diagnostics | Clinical Chemistry | 50000 | 52000 | 52114 | Bilirubin Direct, Serum | Serum | Plasma | 2/0.5 | G (Plasma) or R/Y (Serum) | 6 hours | 2-8 C | RT(15-25°C): 8 hr 2-8C(2-8°C): 7 d Frozen: 7 d (Protect from light by wrapping in foil or transferring to an amber transport vial. Avoid hemolysis.) | Bilirubin Direct,Serum | Diazo | NA | G1. Also See sample stability. | Clinical report |
Under Validation | N/A | Routine Diagnostics | Clinical Chemistry | 50000 | 52000 | 52115 | Total Protein, Serum | Serum | Plasma | 1/0.5 | G (Plasma) or R/Y (Serum) | 6 hours | 2-8 C | R.T.: 8 hr 2-8C: 3 d Frozen: 7 day | Total Protein ,Serum | Biuret | NA | G1 | Clinical report |
Under Validation | N/A | Routine Diagnostics | Clinical Chemistry | 50000 | 52000 | 52116 | Gamma Glutamyl Transferase,Serum | Serum | Plasma | 1/0.5 | G (Plasma) or R/Y (Serum) | 6 hours | 2-8 C | RT(15-25°C) 7 d 2-8C(2-8°C) 7 d | Gamma Glutamyl Transferase,Serum | G-glutamyl-carboxy | NA | G1 | Clinical report |
Under Validation | N/A | Routine Diagnostics | Clinical Chemistry | 50000 | 52000 | 52117 | Creatine Phosphokinase, Serum | Serum | Plasma | 2/0.5 | G (Plasma) or R/Y (Serum) | 6 hours | 2-8 C | R.T.: 8 hr 2-8C: 7 d Frozen: 7 d | Creatine Phosphokinase,Serum | NAC Activated | NA | G1 | Clinical report |
Under Validation | N/A | Routine Diagnostics | Clinical Chemistry | 50000 | 53000 | 52118 | Lactate Dehydrogenase (LDH), Serum | Serum | Plasma | 1/0.5 | G (Plasma) or R/Y (Serum) | 6 hours | 2-8 C | R.T.: 8 hr 2-8C: 3 d Frozen: 7 day | Lactate Dehydrogenase (LDH), Serum | DGKC P→L | NA | G1 | Clinical report |
Under Validation | N/A | Routine Diagnostics | Clinical Chemistry | 50000 | 52000 | 52119 | Amylase, Total, Serum | Serum | Plasma | 1/0.5 | G (Plasma) or R/Y (Serum) | 6 hours | 2-8 C | RT(15-25°C): 7 d 2-8C(2-8°C): 7 d | Amylase,Serum | G7 PNP | NA | G1 | Clinical report |
Under Validation | N/A | Routine Diagnostics | Clinical Chemistry | 50000 | 52000 | 52120 | Urea, Serum | Serum | Plasma | 1/0.5 | G (Plasma) or R/Y (Serum) | 6 hours | 2-8 C | R.T.: 8 hr 2-8C: 7 d Frozen: 7 day | Blood Urea,Serum | Urease, UV | NA | G1 | Clinical report |
Under Validation | N/A | Routine Diagnostics | Clinical Chemistry | 50000 | 52000 | 52121 | Creatinine, Serum | Serum | Plasma | 2/0.5 | G (Plasma) or R/Y (Serum) | 6 hours | 2-8 C | RT(15-25°C): 7 d 2-8C(2-8°C): 30 d | Creatinine,Serum | Enzymatic - Creatininase | NA | G1 | Clinical report |
Under Validation | N/A | Routine Diagnostics | Clinical Chemistry | 50000 | 52000 | 52122 | Uric Acid, Serum | Serum | Plasma | 1/0.5 | G (Plasma) or R/Y (Serum) | 6 hours | 2-8 C | R.T.: 3 d 2-8C: 7 d | Uric Acid,Serum | Uricase | NA | G1 | Clinical report |
Under Validation | N/A | Routine Diagnostics | Clinical Chemistry | 50000 | 52000 | 52123 | Calcium, total, Serum | Serum | Plasma | 2/0.5 | G (Plasma) or R/Y (Serum) | 6 hours | 2-8 C | RT(15-25°C): 7 d 2-8C(2-8°C): 3 weeks | Calcium,Serum | Arsenazo | NA | G1, Anticoagulants other than heparin | Clinical report |
Under Validation | N/A | Routine Diagnostics | Clinical Chemistry | 50000 | 52000 | 52124 | Phosphorus (Inorganic Phosphate), Serum | Serum | Plasma | 1/0.5 | G (Plasma) or R/Y (Serum) | 6 hours | 2-8 C | R.T.: 8 hr 2-8C: 7 d Frozen: 7 day | Phosphorus,Serum | Phosphomolybdate | NA | G1 | Clinical report |
Under Validation | N/A | Routine Diagnostics | Clinical Chemistry | 50000 | 52000 | 52125 | Iron, Serum. | Serum | Plasma | 1/0.5 | G (Plasma) or R/Y (Serum) | 6 hours | 2-8 C | RT(15-25°C) 7 d 2-8C(2-8°C) 3 weeks | Iron, Serum. | TPTZ | NA | G1 | Clinical report |
Under Validation | N/A | Routine Diagnostics | Clinical Chemistry | 50000 | 52000 | 52126 | Haemoglobin A1c,Whole Blood | Whole Blood | 2/0.5 | EDTA | 6 hours | 2-8 C | RT(1 hour) 2-8C(2-8°C) 7 d | Haemoglobin A1c,Whole Blood | IMMUNOTURBIDIMETRIC | NA | G1 | Clinical report | |
Under Validation | N/A | Routine Diagnostics | Clinical Chemistry | 50000 | 52000 | 52127 | Creatinine Clearance, Serum | Serum | Plasma | 5 ML Serum / Plasma | G (Plasma) or R/Y (Serum) | 6 hours | 2-8 C | RT(15-25°C) 7 d 2-8C(2-8°C) 30 d | Creatinine Clearance,Serum | Calculated | NA | G1 | Clinical report |
Under Validation | N/A | Routine Diagnostics | Clinical Chemistry | 50000 | 52000 | 52128 | Antistreptolysin O (ASO) Antibodies | Serum | Plasma | 1/0.5 | R/Y (Serum) | 6 hours | 2-8 C | R.T.: 2 d 2-8C: 8 d | Antistreptolysin O (ASO) Antibodies | Immunoturbidimetric | NA | G1 | Clinical report |
Under Validation | N/A | Routine Diagnostics | Clinical Chemistry | 50000 | 52000 | 52129 | C-Reactive Protein (CRP), Quantitative | Serum | Plasma | 1/0.5 | G/EDTA (Plasma) or R/Y (Serum) | 6 hours | 2-8 C | R.T.: 11 d 2-8C: 2 months | CRP ; C-Reactive Protein, Quantitative | Immunoturbidimetric | NA | G1 | Clinical report |
Under Validation | N/A | Routine Diagnostics | Clinical Chemistry | 50000 | 52000 | 52130 | Rheumatoid Factor, Quantitative, Serum | Serum | Plasma | 1/0.5 | G/EDTA/Blue (Plasma) or R/Y (Serum) | 6 hours | 2-8 C | R.T.: 1 day 2-8C: 8 d Frozen: 3 months | Rheumatoid Factor, Quantitative, Serum | Immunoturbidimetric | NA | G1 | Clinical report |
Under Validation | N/A | Routine Diagnostics | Clinical Chemistry | 50000 | 52000 | 52131 | Magnesium, Serum | Serum | Plasma | 1/0.5 | Y/R | 6 | 2-8 C | R.T.: 8 hr 2-8C: 7 d Frozen: 7 day | Magnesium,Serum | Photometric, Xylidyl blue | N/A | G1 | Clinical report |
Under Validation | N/A | Routine Diagnostics | Clinical Chemistry | 50000 | 52000 | 52132 | 24 hr Urine volume | 24 hrs Urine | N/A | Sterile 24 hr Urine Cont | 6 hours | 2-8 C | N/A | Volume, 24 hr, Urine | manual | NA | G2 | Clinical report | |
Under Validation | N/A | Routine Diagnostics | Clinical Chemistry | 50000 | 52000 | 52133 | Microalbumin,Urine | Spot Urine / 24 hrs Urine | 20 ML | Sterile Cont | 6 hours | 2-8 C | R.T.: 8 hr 2-8C: 4 d Frozen: NA | Microalbumin,Urine | Immunoturbidimetric | First morning sample preferred | G2 | Clinical report | |
Under Validation | N/A | Routine Diagnostics | Clinical Chemistry | 50000 | 52000 | 52134 | Microalbumin / Creatinine Ratio,Urine | Spot Urine / 24 hrs Urine | 20 ML | Sterile Cont | 6 hours | 2-8 C | R.T.: 8 hr 2-8C: 4 d Frozen: NA | Microalbumin / Creatinine Ratio,Urine | Calculated | First morning sample preferred | G2 | Clinical report | |
Under Validation | N/A | Routine Diagnostics | Clinical Chemistry | 50000 | 52000 | 52135 | Creatinine, Urine | Spot Urine / 24 hrs Urine | 20 ML | Sterile Cont | 6 hours | 2-8 C | 30d in Ref(2-8) | Creatinine, Urine | Enzymatic | NA | G2 | Clinical report | |
Under Validation | N/A | Routine Diagnostics | Clinical Chemistry | 50000 | 52000 | 52136 | Protein, 24 hr Urine | 24 hrs Urine | N/A | Sterile 24 hr Urine Contwith no preservatives | 6 hours | 2-8 C | R.T.: 2 hr 2-8C: 3 d Frozen: 7 day | Protein, 24 hr Urine | Biuret | NA | G2 | Clinical report | |
Under Validation | N/A | Routine Diagnostics | Clinical Chemistry | 50000 | 52000 | 52137 | Liver Function Tests,Serum (Available in Profiles Section) | Serum | Plasma | 1/0.5 | G (Plasma) or R/Y (Serum) | 6 hours | 2-8 C | R.T.: 8 hr 2-8C: 7 d Frozen: 7 d | Liver Function Tests,Serum | Refer to individual test | NA | G1. See bilirubin for specific rejection. Anticoagulants other than heparin | Clinical report |
Live | 2021-05-05 00:00:00 | Routine Diagnostics | Clinical Chemistry | 50000 | 52000 | 52138 | hCG, Quantitative, Pregnancy, Serum | Serum | Plasma | 1/0.5 | G/EDTA (Plasma) or R/Y (Serum) | 6 hours | 2-8 C | R.T.: 8 hr 2-8C: 48 hr Frozen: 7 day | Beta HCG, Blood Quantitative | Chemiluminescence (CMIA) | NA | G1 | Clinical report |
Under Validation | N/A | Routine Diagnostics | Clinical Chemistry | 50000 | 52000 | 52139 | Albumin, Serum | Serum | Plasma | 1/0.5 | G (Plasma) or R/Y (Serum) | 6 hours | 2-8 C | R.T.: 8 hr 2-8C: 2 d Frozen: 7 d | Albumin,Serum | BCG | NA | G1 | Clinical report |
Under Validation | N/A | Routine Diagnostics | Clinical Chemistry | 50000 | 52000 | 52140 | Estimated Gfr, Serum | Serum | Plasma | 2/0.5 | G (Plasma) or R/Y (Serum) | 6 hours | 2-8 C | RT(15-25°C): 7 d 2-8C(2-8°C): 30 d | Estimated Gfr,Serum | Calculated | NA | G1 | Clinical report |
Routine Diagnostics | Clinical Chemistry | 50000 | 52000 | 52141 | UIBC, Serum. | Serum | Plasma | 1/0.5 | G (Plasma) or R/Y (Serum) | 6 hours | 2-8 C | RT(15-25°C) 7 d 2-8C(2-8°C) 3 weeks | UIBC, Serum. | TPTZ | NA | G1 | Clinical report | ||
Routine Diagnostics | Clinical Chemistry | 50000 | 52000 | 52142 | Lipase, Serum. | Serum | Plasma | 1/0.5 | G (Plasma) or R/Y (Serum) | 6 hours | 2-8 C | RT(15-25°C) 7 d 2-8C(2-8°C) 3 weeks | Lipase, Serum. | TPTZ | NA | G1 | Clinical report | ||
Routine Diagnostics | Clinical Chemistry | 50000 | 52000 | 52143 | Electrolyte, Serum. (Na,K,Cl) | Serum | Plasma | 1/0.5 | G (Plasma) or R/Y (Serum) | 6 hours | 2-8 C | RT(15-25°C) 7 d 2-8C(2-8°C) 3 weeks | Electrolyte, Serum. | Indirect ISE | NA | G1 | Clinical report | ||
Routine Diagnostics | Clinical Chemistry | 50000 | 52000 | 52144 | Electrolytes, Urine (Na,K,Cl) | Spot Urine / 24 hrs Urine | Spot Urine / 24 hrs Urine | 1/0.5 | Urine Container | 6 hours | 2-8 C | R.T.: 8 hr 2-8C: 48 hr | Electrolytes, Urine (Na,K,Cl) | Indirect ISE | Clinical report | ||||
Routine Diagnostics | Clinical Chemistry | 50000 | 52000 | 52145 | Protein / Creatinine Ratio, Urine (Random) | Spot Urine | Spot Urine | 1/0.5 | Urine Container | 6 hours | 2-8 C | R.T.: 8 hr 2-8C: 48 hr | Protein / Creatinine Ratio, Urine (Random) | Calculated | Clinical report | ||||
Routine Diagnostics | Clinical Chemistry | 50000 | 52000 | 52146 | TIBC, Serum | Serum | Plasma | 1/0.5 | G (Plasma) or R/Y (Serum) | 6 hours | 2-8 C | R.T.: 8 hr 2-8C: 48 hrs Frozen: 7 g | Total Iron Binding Capacity,Serum | Calculated | Clinical report | ||||
Routine Diagnostics | Clinical Chemistry | 50000 | 52000 | 52147 | BUN, Serum | Serum | Plasma | 1/0.5 | G (Plasma) or R/Y (Serum) | 6 hours | 2-8 C | R.T.: 8 hr 2-8C: 48 hr Frozen: 7 d | Blood Urea Nitrogen,Serum | Urease, UV | Clinical report | ||||
Clinical Chemistry | 50000 | 52000 | 52148 | CYCLIC CITRULLINATED PEPTIDE (CCP) Antibody | Serum | 2/1 | Y/R | 12 hours | 2-8 C | R.T.: 8 hr 2-8C: 48 hrs Frozen: 7 g | CCP Antibody | CLIA | N/A | Clinical report | |||||
Clinical Chemistry | 50000 | 52000 | 52149 | Alcohol Ethanol Serum | Serum | 2 ml of Serum | R/Y (Serum) | 12 hours | Alcohol Ethanol | Biochemical | Do Not Use Spirit / Alcohol While Collection.Cap Well. Always collect in Gel vacutainer and Separate by centrifugation at the earliest in same tube. Do not separate serum in another tube | Clinical report | |||||||
Live | 2021-05-05 00:00:00 | Routine Diagnostics | Diagnostic Immunology | 50000 | 53000 | 53001 | Thyroid Stimulating Hormone (TSH), Serum | Serum | Plasma | 1/0.5 | Y/R | 24 | 2-8 C | R.T.: 8 hr 2-8C: 48 hr Frozen: 7 d | TSH | CLIA | N/A | G1 | Clinical report |
Live | 2021-05-05 00:00:00 | Routine Diagnostics | Diagnostic Immunology | 50000 | 53000 | 53002 | Triiodothyronine Free (FT3), Serum | Serum | Plasma | 1/0.5 | Y/R | 24 | 2-8 C | R.T.: 8 hr 2-8C: 48 hr Frozen: 7 d | F.T3 Serum | CLIA | N/A | G1 | Clinical report |
Live | 2021-05-05 00:00:00 | Routine Diagnostics | Diagnostic Immunology | 50000 | 53000 | 53003 | Thyroxine Free (FT4), Serum | Serum | Plasma | 1/0.5 | Y/R | 24 | 2-8 C | R.T.: 8 hr 2-8C: 48 hr Frozen: 7 d | F.T4 Serum | CLIA | N/A | G1 | Clinical report |
Live | 2021-05-05 00:00:00 | Routine Diagnostics | Diagnostic Immunology | 50000 | 53000 | 53004 | Ferritin, Serum | Serum | Plasma | 1/0.5 | Y/R | 24 | 2-8 C | R.T.: 8 hr 2-8C: 48 hr Frozen: 7 d | Ferritin,Serum | CLIA | N/A | G1 | Clinical report |
Live | 2021-05-05 00:00:00 | Routine Diagnostics | Diagnostic Immunology | 50000 | 53000 | 53005 | Follicle-Stimulating Hormone (FSH), Serum | Serum | Plasma | 1/0.5 | Y/R | 24 | 2-8 C | R.T.: 8 hr 2-8C: 48 hr Frozen: 7 d | FSH | CLIA | N/A | G1 | Clinical report |
Live | 2021-05-05 00:00:00 | Routine Diagnostics | Diagnostic Immunology | 50000 | 53000 | 53006 | Luteinizing Hormone (LH), Serum | Serum | Plasma | 1/0.5 | Y/R | 24 | 2-8 C | R.T.: 8 hr 2-8C: 48 hr Frozen: 7 d | LH | CLIA | N/A | G1 | Clinical report |
Live | 2021-05-05 00:00:00 | Routine Diagnostics | Diagnostic Immunology | 50000 | 53000 | 53007 | Prolactin, Serum | Serum | Plasma | 1/0.5 | Y/R | 24 | 2-8 C | R.T.: 8 hr 2-8C: 48 hr Frozen: 7 d | Prolactin | CLIA | N/A | G1 | Clinical report |
Live | 2021-05-05 00:00:00 | Routine Diagnostics | Diagnostic Immunology | 50000 | 53000 | 53008 | Progesterone, Serum | Serum | Plasma | 1/0.5 | Y/R | 24 | 2-8 C | R.T.: 8 hr 2-8C: 48 hr Frozen: 7 d | Progesterone, Serum | CLIA | N/A | G1 | Clinical report |
Live | 2021-05-05 00:00:00 | Routine Diagnostics | Diagnostic Immunology | 50000 | 53000 | 53009 | Prostate Specific Antigen (PSA), Free, Serum | Serum | Plasma | 1/0.5 | Y/R | 24 | 2-8 C | R.T.: 8 hr 2-8C: 48 hr Frozen: 7 d | Prostate Specific Antigen (PSA), Free, Serum | CLIA | N/A | G1 | Clinical report |
Live | 2021-05-05 00:00:00 | Routine Diagnostics | Diagnostic Immunology | 50000 | 53000 | 53010 | Prostate Specific Antigen (PSA), Total, Serum | Serum | Plasma | 1/0.5 | Y/R | 24 | 2-8 C | R.T.: 8 hr 2-8C: 48 hr Frozen: 7 d | Prostate Specific Antigen (PSA), Total, Serum | CLIA | N/A | G1 | Clinical report |
Live | 2021-05-05 00:00:00 | Routine Diagnostics | Diagnostic Immunology | 50000 | 53000 | 53011 | Insulin, Random | Serum | Plasma | 1/0.5 | Y/R | 24 | 2-8 C | R.T.: 8 hr 2-8C: 48 hr Frozen: 7 d | Insulin, Random | CLIA | N/A | G1 | Clinical report |
Live | 2021-05-05 00:00:00 | Routine Diagnostics | Diagnostic Immunology | 50000 | 53000 | 53012 | 1,25 Dihydroxy Vitamin D, Serum | Serum | Plasma | 1/0.5 | Y/R | 24 | 2-8 C | R.T.: 8 hr 2-8C: 48 hr Frozen: 7 d | 1,25 Dihydroxy Vitamin D, Serum | CLIA | N/A | G1 | Clinical report |
Live | 2021-05-05 00:00:00 | Routine Diagnostics | Diagnostic Immunology | 50000 | 53000 | 53013 | Vitamin B 12, Serum | Serum | Plasma | 1/0.5 | Y/R | 24 | 2-8 C | R.T.: 8 hr 2-8C: 48 hr Frozen: 7 d | Vit B12 | CLIA | N/A | G1 | Clinical report |
Live | 2021-05-05 00:00:00 | Routine Diagnostics | Diagnostic Immunology | 50000 | 53000 | 53014 | Hepatitis B Surface Antigen (HBs Ag), Qualtitative, Serum | Serum | Plasma | 1/0.5 | Y/R | 24 | 2-8 C | R.T.: 8 hr 2-8C: 48 hr Frozen: 7 d | Hbs Ag | CLIA | N/A | G1 | Clinical report |
Live | 2021-05-05 00:00:00 | Routine Diagnostics | Diagnostic Immunology | 50000 | 53000 | 53015 | HIV 1&2 Antibody and Antigen, Serum | Serum | Plasma | 1/0.5 | Y/R | 24 | 2-8 C | R.T.: 8 hr 2-8C: 48 hr Frozen: 7 d | HIV | CLIA | N/A | G1 | Clinical report |
Live | 2021-05-05 00:00:00 | Routine Diagnostics | Diagnostic Immunology | 50000 | 53000 | 53016 | Hepatitis C antibody (HCV), Serum | Serum | Plasma | 1/0.5 | Y/R | 24 | 2-8 C | R.T.: 8 hr 2-8C: 48 hr Frozen: 7 d | HCV | CLIA | N/A | G1 | Clinical report |
Live | 2021-05-05 00:00:00 | Routine Diagnostics | Diagnostic Immunology | 50000 | 53000 | 53017 | Hepatitis B Surface Antibody (HBs Ab), Quantitative, Serum | Serum | Plasma | 1/0.5 | Y/R | 24 | 2-8 C | R.T.: 8 hr 2-8C: 48 hr Frozen: 7 d | Anti-HbS | CLIA | N/A | G1 | Clinical report |
Live | 2021-05-05 00:00:00 | Routine Diagnostics | Diagnostic Immunology | 50000 | 53000 | 53018 | Rubella Ab, IgG, Serum | Serum | Plasma | 1/0.5 | Y/R | 24 | 2-8 C | R.T.: 8 hr 2-8C: 48 hr Frozen: 7 d | Rubella IgG | CLIA | N/A | G1 | Clinical report |
Live | 2021-05-05 00:00:00 | Routine Diagnostics | Diagnostic Immunology | 5000 | 53000 | 53019 | Anti-SARS-CoV-2-S - Quantitative | Serum | Plasma | 1/0.5 | Y/R (Serum) or G (Plasma) | Runing Day/Every day @2pm | 2-8 C | RT : 7 d; 2-8 C: 2week; Frozen: 30 d | Anti-SARS-CoV-2-S - Quantitative | CLIA | NA | Clinical report | |
Phase II | If we have enough sample will be ready within 10 days | Routine Diagnostics | Diagnostic Immunology | 50000 | 53000 | 53020 | DHEA, Serum | Serum | Plasma | 1/0.5 | Y/R | 24 | 2-8 C | R.T.: 8 hr 2-8C: 48 hr Frozen: 7 d | Dehydroepiandrosterone (DHEA) | CLIA | N/A | G1 | Clinical report |
Phase II | If we have enough sample will be ready within 10 days | Routine Diagnostics | Diagnostic Immunology | 50000 | 53000 | 53021 | TPO (Ab) | Serum | Plasma | 1/0.5 | Y/R | 24 | 2-8 C | R.T.: 8 hr 2-8C: 48 hr Frozen: 7 d | Thyroid Peroxidase (TPO) Antibodies | CLIA | N/A | G1 | Clinical report |
Phase II | If we have enough sample will be ready within 10 days | Routine Diagnostics | Diagnostic Immunology | 50000 | 53000 | 53022 | TG (Ab) | Serum | Plasma | 1/0.5 | Y/R | 24 | 2-8 C | R.T.: 8 hr 2-8C: 48 hr Frozen: 7 d | Thyroglobulin Antibody | CLIA | N/A | G1 | Clinical report |
Phase II | If we have enough sample will be ready within 10 days | Routine Diagnostics | Diagnostic Immunology | 50000 | 53000 | 53024 | Estradiol | Serum | Plasma | 1/0.5 | Y/R | 24 | 2-8 C | R.T.: 8 hr 2-8C: 48 hr Frozen: 7 d | Estradiol | CLIA | N/A | G1 | Clinical report |
Routine Diagnostics | Diagnostic Immunology | 50000 | 53000 | 53025 | Triiodothyronine,Total (T3), Serum | Serum | Plasma | 1/0.5 | Y/R | 24 | 2-8 C | R.T.: 8 hr 2-8C: 48 hr Frozen: 7 d | T3 Serum | CLIA | N/A | G1 | Clinical report | ||
Routine Diagnostics | Diagnostic Immunology | 50000 | 53000 | 53026 | Triiodothyronine,Total (T4), Serum | Serum | Plasma | 1/0.5 | Y/R | 24 | 2-8 C | R.T.: 8 hr 2-8C: 48 hr Frozen: 7 d | T4 Serum | CLIA | N/A | G1 | Clinical report | ||
Routine Diagnostics | Diagnostic Immunology | 50000 | 53000 | 53027 | Folate, Serum | Serum | Plasma | 1/0.5 | Y/R | 24 | 2-8 C | R.T.: 8 hr 2-8C: 48 hr Frozen: 7 d | Folate (Folic Acid), Serum | CLIA | N/A | G1 | Clinical report | ||
Routine Diagnostics | Diagnostic Immunology | 5000 | 53000 | 53028 | Testosterone | Serum | Plasma | 1/0.5 | Y/R (Serum) or G (Plasma) | Runing Day/Every day @2pm | 2-8 C | RT : 7 d; 2-8 C: 2week; Frozen: 30 d | Testosterone, Total | CLIA | This test may exhibit interference when sample is collected from a person who is consuming a supplement with a high dose of biotin (also termed as vitamin B7 or B8, vitamin H, or coenzyme R). It is recommended to ask all patients who may be indicated for this test about biotin supplementation. Patients should be cautioned to stop biotin consumption at least 72 hours prior to the collection of a sample. | Clinical report | |||
Routine Diagnostics | Diagnostic Immunology | 5000 | 53000 | 53029 | CMV, IgG | Serum | Plasma | 1/0.5 | Y/R (Serum) or G (Plasma) | Runing Day/Every day @2pm | 2-8 C | RT : 7 d; 2-8 C: 2week; Frozen: 30 d | Cytomegalovirus (CMV) Antibodies, IgG | CLIA | NA | Clinical report | |||
Routine Diagnostics | Diagnostic Immunology | 5000 | 53000 | 53030 | CA 125 | Serum | Plasma | 1/0.5 | Y/R (Serum) or G (Plasma) | Runing Day/Every day @2pm | 2-8 C | RT : 7 d; 2-8 C: 2week; Frozen: 30 d | Cancer Antigen (CA) 125 | CLIA | It is suggested that the assay not be performed until at least three weeks after the completion of primary chemotherapy and at least two months following abdominal surgery | Clinical report | |||
Routine Diagnostics | Diagnostic Immunology | 5000 | 53000 | 53031 | CA 19-9 | Serum | Plasma | 1/0.5 | Y/R (Serum) or G (Plasma) | Runing Day/Every day @2pm | 2-8 C | RT : 7 d; 2-8 C: 2week; Frozen: 30 d | Carbohydrate Antigen (CA) 19-9 | CLIA | NA | Clinical report | |||
Routine Diagnostics | Diagnostic Immunology | 5000 | 53000 | 53032 | CA 15-3 | Serum | Plasma | 1/0.5 | Y/R (Serum) or G (Plasma) | Runing Day/Every day @2pm | 2-8 C | RT : 7 d; 2-8 C: 2week; Frozen: 30 d | Cancer Antigen (CA) 15-3 | CLIA | NA | Clinical report | |||
Routine Diagnostics | Diagnostic Immunology | 5000 | 53000 | 53033 | CEA | Serum | Plasma | 1/0.5 | Y/R (Serum) or G (Plasma) | Runing Day/Every day @2pm | 2-8 C | RT : 7 d; 2-8 C: 2week; Frozen: 30 d | Carcinoembryonic Antigen (CEA) | CLIA | NA | Clinical report | |||
Routine Diagnostics | Diagnostic Immunology | 5000 | 53000 | 53034 | PTH | Serum | Plasma | 1/0.5 | Y/R (Serum) or G (Plasma) | Runing Day/Every day @2pm | 2-8 C | RT : 7 d; 2-8 C: 2week; Frozen: 30 d | Parathyroid Hormone (PTH) | CLIA | NA | Clinical report | |||
Routine Diagnostics | Diagnostic Immunology | 5000 | 53000 | 53035 | AMH | Serum | Plasma | 1/0.5 | Y/R (Serum) or G (Plasma) | Runing Day/Every day @2pm | Frozen | Frozen: 30 d | Anti-Müllerian Hormone (AMH) | CLIA | NA | Clinical report | |||
Routine Diagnostics | Diagnostic Immunology | 5000 | 53000 | 53036 | Toxo, IgG | Serum | Plasma | 1/0.5 | Y/R (Serum) or G (Plasma) | Runing Day/Every day @2pm | 2-8 C | RT : 7 d; 2-8 C: 2week; Frozen: 30 d | Toxoplasma gondii Antibodies, IgG | CLIA | NA | Clinical report | |||
Routine Diagnostics | Diagnostic Immunology | 5000 | 53000 | 53037 | AFP | Serum | Plasma | 1/0.5 | Y/R (Serum) or G (Plasma) | Runing Day/Every day @2pm | 2-8 C | RT : 7 d; 2-8 C: 2week; Frozen: 30 d | Alpha-Fetoprotein (AFP), Serum, Tumor Marker | CLIA | NA | Clinical report | |||
Routine Diagnostics | Diagnostic Immunology | 5000 | 53000 | 53038 | Anti-HAV, IgM | Serum | Plasma | 1/0.5 | Y/R (Serum) or G (Plasma) | Runing Day/Every day @2pm | 2-8 C | RT : 7 d; 2-8 C: 2week; Frozen: 30 d | Antibody to Hepatitis A Virus, IgM | CLIA | NA | Clinical report | |||
Live | 2021-05-30 00:00:00 | Routine Diagnostics | Clinical Microscopy | 50000 | 54000 | 54001 | Urine Routine Analysis | Spot Urine | Urine | 20 ML | Sterile Cont | 6 hours | 2-8 C | R.T.: 8 hr 2-8C: 4 d Frozen: NA | Urine Routine Analysis | Manual | N/A | G1(>2 hour if without preservative or >48 hr with preservative). samples sent uncovered especially for tests such as Bilirubin, Urobilinogen and/or porphobilinogen. | Clinical report |
Live | 2021-05-30 00:00:00 | Routine Diagnostics | Clinical Microscopy | 50000 | 54000 | 54002 | Stool Parasites Microscopy, Stool | Stool | 5/3 mL | Sterile Cont | 6 hours | 2-8 C | R.T (without media): 1hr; R.T (with media): 24 hr; 2-8: 24 hr | Stool Analysis | Manual | N/A | G2. Frozen sample | Clinical report | |
Phase II | 2021-05-31 00:00:00 | Routine Diagnostics | IMMUNOLOGY / SEROLOGY | 50000 | 55000 | 55001 | Calprotectin,Stool | Stool | Stool | 1/0.5 | Sterile Cont | 6 hours | 2-8 C | R.T (without media): 1hr; R.T (with media): 24 hr; 2-8: 24 hr | Calprotectin,Stool | Clinical report | |||
Phase II | 2021-05-31 00:00:00 | Routine Diagnostics | IMMUNOLOGY / SEROLOGY | 50000 | 55000 | 55002 | Adenovirus Antigen , Stool | Stool | Stool | 1/0.5 | Sterile Cont | 6 hours | 2-8 C | R.T (without media): 1hr; R.T (with media): 24 hr; 2-8: 24 hr | Adenovirus Antigen , Stool | Fluorescence immunoassay (FIA) | N/A | G1 | Clinical report |
Phase II | 2021-05-31 00:00:00 | Routine Diagnostics | IMMUNOLOGY / SEROLOGY | 50000 | 55000 | 55003 | H. Pylori Antigen, Stool | Stool | Stool | 1/0.5 | Sterile Cont | 6 hours | 2-8 C | R.T (without media): 1hr; R.T (with media): 24 hr; 2-8: 24 hr | H. Pylori Antigen, Stool | Fluorescence immunoassay (FIA) | N/A | G1 | Clinical report |
Phase II | 2021-05-31 00:00:00 | Routine Diagnostics | IMMUNOLOGY / SEROLOGY | 50000 | 55000 | 55004 | Rotavirus Antigen , Stool | Stool | Stool | 1/0.5 | Sterile Cont | 6 hours | 2-8 C | R.T (without media): 1hr; R.T (with media): 24 hr; 2-8: 24 hr | Rotavirus Antigen , Stool | Fluorescence immunoassay (FIA) | N/A | G1 | Clinical report |
Phase II | 2021-05-31 00:00:00 | Routine Diagnostics | IMMUNOLOGY / SEROLOGY | 50000 | 55000 | 55005 | Clostridium Difficile Toxin,Stool | Stool | Stool | 1/0.5 | Sterile Cont | 6 hours | 2-8 C | R.T (without media): 1hr; R.T (with media): 24 hr; 2-8: 24 hr | Clostridium Difficile Toxin,Stool | Fluorescence immunoassay (FIA) | N/A | G1 | Clinical report |
Phase II | 2021-05-31 00:00:00 | Routine Diagnostics | IMMUNOLOGY / SEROLOGY | 50000 | 55000 | 55006 | E.Coli Antigen, Stool | Stool | Stool | 1/0.5 | Sterile Cont | 6 hours | 2-8 C | R.T (without media): 1hr; R.T (with media): 24 hr; 2-8: 24 hr | E.Coli Antigen, Stool | Fluorescence immunoassay (FIA) | N/A | G1 | Clinical report |
Phase II | 2021-05-31 00:00:00 | Routine Diagnostics | IMMUNOLOGY / SEROLOGY | 50000 | 55000 | 55007 | E.Histolytica Antigen, Stool | Stool | Stool | 1/0.5 | Sterile Cont | 6 hours | 2-8 C | R.T (without media): 1hr; R.T (with media): 24 hr; 2-8: 24 hr | E.Histolytica Antigen, Stool | Fluorescence immunoassay (FIA) | N/A | G1 | Clinical report |
Phase II | 2021-05-31 00:00:00 | Routine Diagnostics | IMMUNOLOGY / SEROLOGY | 50000 | 55000 | 55009 | Influenza A&B Virus Antigen | Nasal/Throat/NPH Swab; nasal/NPH aspirate or wash | Nasal/Throat/NPH Swab; nasal/NPH aspirate or wash | 2 Swab | Sterile Swab | 6 hours | 2-8 C | Test immediately otherwise refrigerate at 2-8C.; 2-8C: 8hr | Influenza A&B Virus Antigen | Fluorescence immunoassay (FIA) | N/A | G2 | Clinical report |
Phase II | 2021-05-31 00:00:00 | Routine Diagnostics | IMMUNOLOGY / SEROLOGY | 50000 | 55000 | 55010 | Occult Blood, Fecal | Stool | Stool | 1/0.5 | Sterile Cont | 6 hours | 2-8 C | R.T (without media): 1hr; R.T (with media): 24 hr; 2-8: 24 hr | Occult Blood, Fecal, | N/A | G1 | Clinical report | |
Phase II | 2021-05-31 00:00:00 | Routine Diagnostics | IMMUNOLOGY / SEROLOGY | 50000 | 55000 | 55011 | MYCOPLASMA PNEUMONIAE ANTIBODY - IgM | Serum | 1ml | R/Y (Serum) | 6 hours | 2-8 C | R.T (without media): 1hr; R.T (with media): 24 hr; 2-8: 24 hr | MYCOPLASMA PNEUMONIAE ANTIBODY - IgM | Fluorescence immunoassay (FIA) | N/A | G1 | Clinical report | |
Legends | |||||||||||||||||||
G1: | Labelling error, Sample hemolyzed, leaky container, Insufficient sample, wrong tube, Specimen received beyond stability time | ||||||||||||||||||
G2: | Labelling error, leaky container, Insufficient sample, wrong tube, Specimen received beyond stability time | ||||||||||||||||||
NPH | Nasopharyngeal; | ||||||||||||||||||
G3: | Labelling error, Sample hemolyzed, Clotted sample, leaky Cont, Insufficient sample, wrong tube, Specimen received beyond stability time | ||||||||||||||||||
G4: | Do not reject. Call Pathologist in case of any sample error/discrepancy |